Resalis Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Early Stage VC
- Investors
-
8
Resalis Therapeutics General Information
Description
Developer of non-coding RNA-based therapeutics designed to address metabolic disorders such as obesity and fatty liver disease. The company's platform leverages expertise in lipid metabolism and RNA modalities, enabling doctors to use a disease-modifying approach to treat metabolic dysfunction with its lead candidate.
Contact Information
Website
www.resalistherapeutics.comCorporate Office
- Via Ettore de Sonnaz 19
- 10121 Turin
- Italy
Corporate Office
- Via Ettore de Sonnaz 19
- 10121 Turin
- Italy
Resalis Therapeutics Timeline
Resalis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 28-Oct-2024 | Completed | Clinical Trials - Phase 1 | |||
| 4. Early Stage VC (Series A) | 05-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 2. Seed Round | 15-Feb-2023 | $10.8M | $17.9M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 05-Aug-2021 | $7.1M | $7.1M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Resalis Therapeutics Comparisons
Industry
Financing
Details
Resalis Therapeutics Competitors (1)
One of Resalis Therapeutics’s competitors is HemoShear Therapeutics, a Venture Capital-Backed company based in Charlottesville, VA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HemoShear Therapeutics | Venture Capital-Backed | Charlottesville, VA |
Resalis Therapeutics Patents
Resalis Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4807003-A1 | Method and compounds to address ageing | Pending | 10-Mar-2025 | ||
| WO-2026190663-A1 | Methods and compounds to address ageing | Pending | 10-Mar-2025 | ||
| EP-4353823-A1 | Inhibitors of micro-rna 22 | Pending | 12-Oct-2022 | ||
| JP-2024057599-A | Inhibitors of micro-rna 22 | Pending | 12-Oct-2022 | ||
| US-12691135-B2 | Inhibitors of micro-rna 22 | Active | 14-Mar-2018 | A61K31/7125 |
Resalis Therapeutics Signals
Resalis Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Sanofi | Corporation | Minority | ||
| Sunstone Life Science Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| B-Engine | Venture Capital | Minority | ||
| Claris Ventures | Venture Capital | Minority |
Resalis Therapeutics FAQs
-
When was Resalis Therapeutics founded?
Resalis Therapeutics was founded in 2021.
-
Where is Resalis Therapeutics headquartered?
Resalis Therapeutics is headquartered in Turin, Italy.
-
What is the size of Resalis Therapeutics?
Resalis Therapeutics has 9 total employees.
-
What industry is Resalis Therapeutics in?
Resalis Therapeutics’s primary industry is Drug Discovery.
-
Is Resalis Therapeutics a private or public company?
Resalis Therapeutics is a Private company.
-
What is Resalis Therapeutics’s current revenue?
The current revenue for Resalis Therapeutics is .
-
How much funding has Resalis Therapeutics raised over time?
Resalis Therapeutics has raised $28.9M.
-
Who are Resalis Therapeutics’s investors?
Sanofi, Sunstone Life Science Ventures, , B-Engine, and Claris Ventures are 5 of 8 investors who have invested in Resalis Therapeutics.
-
Who are Resalis Therapeutics’s competitors?
HemoShear Therapeutics is a competitor of Resalis Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process